HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influence of killer cell immunoglobulin-like receptor genotypes on acute graft-vs-host disease after unrelated hematopoietic stem cell transplantation in Koreans.

Abstract
Interactions between killer cell immunoglobulin-like receptors (KIRs) and human leukocyte antigen class I ligands influence the development of the natural killer cell repertoire and the responses to infection, cancer, and allogeneic tissue. In this study, the association of KIR genes with acute graft-vs-host disease (GVHD) was investigated in 44 pairs of leukemia patients and their unrelated donors for hematopoietic stem cell transplantation (HSCT). Donors with more than 12 KIR genes showed significantly decreased frequencies of severe acute GVHD compared with donors with less than 11 KIR genes (P < 0.05). The distribution of KIR genotypes was not different between severe and mild acute GVHD in patients and donors, respectively. These results suggest that the number of KIR genes in donors could influence the occurrence of acute GVHD after unrelated HSCT.
AuthorsS-Y Kim, H-B Choi, H-Y Yoon, E-J Choi, B Cho, H-K Kim, Y-J Kim, H-J Kim, C-K Min, D-W Kim, J-W Lee, W-S Min, C-C Kim, T-G Kim
JournalTissue antigens (Tissue Antigens) Vol. 69 Suppl 1 Pg. 114-7 (Apr 2007) ISSN: 0001-2815 [Print] England
PMID17445182 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HLA-C Antigens
  • Receptors, Immunologic
  • Receptors, KIR
Topics
  • Acute Disease
  • Graft vs Host Disease (etiology)
  • Graft vs Leukemia Effect
  • HLA-C Antigens (physiology)
  • Hematopoietic Stem Cell Transplantation
  • Histocompatibility Testing
  • Humans
  • Killer Cells, Natural (immunology)
  • Korea
  • Leukemia (complications, immunology, therapy)
  • Receptors, Immunologic (genetics, immunology)
  • Receptors, KIR
  • Tissue Donors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: